These high-yield stocks can provide regular dividend payments, creating a steady income stream that many investors find attractive compared to growth-only stocks.
Our analysts believe these stocks may be undervalued relative to their dividend history, potentially offering both income and price appreciation if markets recognize their value.
From real estate and energy to shipping and financial services, this collection offers exposure to multiple dividend-focused sectors in a single convenient group.
These stocks offer attractive dividend yields relative to their current prices. From REITs and energy partnerships to financial services and shipping companies, they represent sectors that traditionally prioritize returning value to shareholders through regular dividend payments.
High-yield stocks can provide steady income, but they often come with higher risk profiles. These companies are currently undervalued compared to their historical dividend payments, suggesting potential value. Consider these as part of a balanced portfolio rather than your entire investment strategy.
We've selected companies across diverse sectors including REITs, natural resources, shipping, and financial services. Each has demonstrated a commitment to maintaining dividend payments, creating potential income opportunities for investors looking beyond just stock price appreciation.
Summary of total market capitalisation and implications of large-cap concentration for the 'High Yielding Stocks' basket.
IEP: $4.69B
OXLC: $1.35B
AGNC: $10.78B
Here are a few of the assets in this group. Create an account to unlock the full list.
애널리스트들은 이 그룹의 자산이 향후 1년간 평균 88.4% 성장할 것으로 예상합니다.
이 그룹의 자산 7개 중 4개가 전문 애널리스트로부터 매수 의견을 받았습니다.
Use the growth calculator to see how much investing in these assets could return over one year, based on aggregated analyst sentiment provided by Refinitive Ltd.
이 자산들에 투자했다면:
12개월 후 예상 가치:
+88.40%
이 바스켓의 전체 스토리를 확인하세요. 리스크와 잠재력을 다룬 상세 기사를 읽어보세요.
인사이트 전체 읽기
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Part of Exinity Group 2015, serving over a million customers globally.
Earn 6% AER on uninvested cash with daily interest payments.
Gilead Sciences has secured FDA approval for a new once-daily HIV combination pill, streamlining therapy for millions of suppressed patients. This regulatory milestone spotlights investment opportunities in pioneering biopharmaceutical companies and drug delivery developers focused on advanced antiviral treatments.
Disney is suing the FCC to block an early license review of its ABC stations, arguing the move is politically motivated retaliation against its news coverage. This unprecedented legal battle highlights the growing regulatory risks for traditional broadcasters and underscores the structural advantages of unregulated digital streaming platforms.
SK Hynix has unveiled a record-breaking 40 trillion won share buyback fueled by soaring demand for its AI memory chips. This historic capital return creates a compelling investment theme centered on high-bandwidth memory producers and the specialized equipment manufacturers that enable their advanced production.
